Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Mylan Wins FDA Approval of First Generic for Estrace Cream

The FDA approved Mylan’s Estradiol Vaginal Cream USP 0.01%, the first generic version of Allergan’s Estrace.

Read More »

China: U.S. should do more to cut opioid demand

The United States should take action to reduce demand for the drugs fueling its deadly opioid crisis, a top Chinese drug control official said.

Read More »

Obamacare enrollment figure dips to 8.7 million

About 8.7 million people enrolled in healthcare plans for 2018 using the federal Obamacare marketplace, according to updated government figures.

Read More »

Germany’s Vetter Begins Construction on $350M 500-Job U.S. HQ

Vetter Pharma – a Germany-based contract company specializing in aseptic filling and packaging of drugs into syringes, vials and cartridges – broke ground on its U.S. headquarters in Des Plaines, Illinois.

Read More »

Four Top-Performing S&P 500 Biotech Stocks of 2017

Todd Campbell, writing for The Motley Fool, notes four biopharma stocks that topped out in the S&P 500 in 2017.

Read More »

Fresenius Allegedly Ignored Hundreds of Bad Quality Tests at Plant in India

The U.S. Food and Drug Administration issued a warning letter to Fresenius Kabi AG of Germany for its plant in India.

Read More »

Five Biotechs Awaiting FDA Decisions in January 2018

Here are five companies looking at possible drug approvals in January 2018.

Read More »

NDA Filing Accepted for GW’s Epidiolex

GW Pharmaceuticals plc announced that the U.S. FDA accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for Epidiolex (cannabidiol or CBD) as an investigational treatment for seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome.

Read More »

Male doctors make a lot more in industry payments than female peers

Male physicians in the U.S. – across almost every specialty – took in more money from the biomedical industry in 2015 than their female peers, a new study suggests.

Read More »

Theranos Avoids Bankruptcy by Snagging $100M Lifeline From Fortress

The Wall Street Journal reported that Theranos Inc. secured a loan from Fortress Investment Group.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom